Milestone Scientific (NYSEAMERICAN:MLSS) Trading 9.2% Higher

Milestone Scientific Inc. (NYSEAMERICAN:MLSSGet Rating)’s share price traded up 9.2% during mid-day trading on Thursday . The stock traded as high as $0.97 and last traded at $0.95. 175,900 shares changed hands during mid-day trading, an increase of 24% from the average session volume of 141,929 shares. The stock had previously closed at $0.87.

Separately, Maxim Group reduced their target price on shares of Milestone Scientific from $6.00 to $4.00 in a report on Monday, April 4th.

The company has a market cap of $65.01 million, a PE ratio of -10.56 and a beta of 1.34.

Milestone Scientific (NYSEAMERICAN:MLSSGet Rating) last released its quarterly earnings results on Tuesday, May 17th. The medical instruments supplier reported ($0.03) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.03). Milestone Scientific had a negative net margin of 79.28% and a negative return on equity of 39.43%. Equities analysts expect that Milestone Scientific Inc. will post -0.1 EPS for the current year.

In other news, Director Neal I. Goldman acquired 54,851 shares of the business’s stock in a transaction on Wednesday, June 1st. The shares were acquired at an average price of $0.89 per share, for a total transaction of $48,817.39. Following the completion of the transaction, the director now directly owns 1,139,873 shares of the company’s stock, valued at approximately $1,014,486.97. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. In the last quarter, insiders have acquired 88,362 shares of company stock worth $76,329 and have sold 45,252 shares worth $59,483. Insiders own 21.43% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. grew its holdings in shares of Milestone Scientific by 141.0% in the third quarter. BlackRock Inc. now owns 198,352 shares of the medical instruments supplier’s stock worth $371,000 after purchasing an additional 116,045 shares during the last quarter. Sequoia Financial Advisors LLC bought a new position in Milestone Scientific during the 1st quarter worth about $86,000. Oppenheimer & Co. Inc. grew its holdings in Milestone Scientific by 26.7% during the 4th quarter. Oppenheimer & Co. Inc. now owns 47,500 shares of the medical instruments supplier’s stock worth $98,000 after acquiring an additional 10,000 shares in the last quarter. Jane Street Group LLC bought a new position in Milestone Scientific during the 1st quarter worth about $35,000. Finally, Royal Bank of Canada bought a new position in Milestone Scientific during the 1st quarter worth about $30,000. Hedge funds and other institutional investors own 8.82% of the company’s stock.

Milestone Scientific Company Profile (NYSEAMERICAN:MLSS)

Milestone Scientific Inc designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic.

Featured Articles

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.